Squarepoint
INAB icon

Squarepoint’s IN8bio INAB Stock Holding History

Squarepoint’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.4K Buy
+10,836
New +$12.7K ﹤0.01% 4342

Other funds holding INAB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Texas Capital Bank Wealth Management Services
Texas Capital Bank Wealth Management Services Dallas, Texas $1.94B AUM 19.18% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Squarepoint's INAB Position: Q3 2026 in Review

Squarepoint opened a new position in IN8bio (INAB) in Q3 2026: 10,836 shares worth $14.4K. The stake represents ﹤0.01% of the portfolio and ranks #4342 among its holdings.

5 funds tracked by Wall St. Rank hold INAB as of Q3 2026.

  • Squarepoint held 10,836 shares of IN8bio worth $14.4K as of Q3 2026.
  • IN8bio was a new Squarepoint position in Q3 2026.
  • IN8bio made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4342 holding.
  • 5 funds tracked by Wall St. Rank held IN8bio as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.